Skip to main content
. 2020 Nov 10;91(4):e2020165. doi: 10.23750/abm.v91i4.10564

Table 1.

Drugs used in our patient population that may potentially cause eosinophilia (adapted from Ref. 12)

Drug Type of reported reaction Percentage and severity of eosinophilia
Chloroquine and Hydroxychloroquine Pulmonary and Immunologic Drug reaction with eosinophilia and systemic symptomsDRESS syndromeSevere based on case reports, frequency not defined
Macrolides: Azithromycin Pulmonary and dermal Eosinophilia <1%, (severity unclear)
Vancomycin Dermal and renal Eosinophilia 1-10% (moderate to severe, reversible)
Teicoplanin Dermal and renal Eosinophilia <1%, (severity unclear)
Cephalosporins Cardiac, pulmonary and dermal Usually mild and self-limiting
Ceftriaxone Cardiac, pulmonary and dermal Eosinophilia 6%, (mild)
Cefuroxime Pulmonary and dermal Eosinophilia 1-7%, (mild)
Cefepime Pulmonary and dermal Eosinophilia 2%, (mild)
Piperacillin tazobactam Renal and dermal Eosinophilia frequency not defined, (mild).
Sulphonamides Pulmonary and cardiac Not usually reported, (could be severe)
Trimethoprim-sulfamethoxazole(Co-trimoxazole). Pulmonary and cardiac Eosinophilia frequency not defined, (mild to moderate)